The STEP 1 trial showed an average weight loss of 14.9% of body weight at 68 weeks
Semaglutide was originally developed for Type 2 diabetes management under the brand name Ozempic
Here is the complete dosage chart for 2.5mg/mL concentration: One challenge with 2.5mg/mL is that the higher doses require larger unit measurements that approach the capacity limits of standard insulin syringes
Month 3 (of consistent use) - there will be a noticeable change skin texture, plumpness in skin tone and texture, lightened tan lines, drastic reduction in hair fall, more fuller head of healthier looking hair, lowered susceptibility to cold and cough, overall better and lighter feel
Treatment decisions require individual clinical evaluation
Could it find its place in competitive sports, and is it useful for recreational exercise